Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA Partners With FCC To Spur Wireless Health Technology Development

This article was originally published in The Gray Sheet

Executive Summary

Manufacturers attending a meeting last week on the convergence of wireless communications and medical devices were encouraged by a new agreement between FDA and the Federal Communications Commission to clarify regulations for the burgeoning product category

You may also be interested in...



FDA/FCC Workshop To Tackle Wireless Medical Test Beds

Infrastructure for evaluating the wireless properties of medical devices will be the subject of a joint FDA and Federal Communications Commission workshop scheduled for March 31.

FDA Aims To Stay Ahead Of Wireless Technology Upgrades With Final Guidance

A final guidance released last week attempts to adopt a flexible approach to regulating the rapidly evolving category of devices that employ radiofrequency wireless technology.

U.S. mHealth Stakeholders Seek To Eliminate Barriers To Growth

Federal agencies and mHealth industry players met with Federal Communications Commission officials June 6 to brainstorm ways of spurring growth in the sector.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT029193

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel